Bone-Building Pills Appear to Lower Invasive Breast Cancer Risk

THURSDAY, June 24 (HealthDay News) -- Bone-building drugs known as bisphosphonates appear to reduce the risk of invasive breast cancer by around 30 percent, two new studies show.